Heidelberg Pharma Valuation
| HPHA Stock | EUR 2.56 0.10 4.07% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Heidelberg Pharma retains a regular Real Value of €2.11 per share. The prevalent price of the firm is €2.56. Our model calculates the value of Heidelberg Pharma from evaluating the firm fundamentals such as EBITDA of (24.84 M), price to book of 24.79 X, and Current Valuation of 194.72 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Heidelberg Pharma's price fluctuation is very risky at this time. Calculation of the real value of Heidelberg Pharma is based on 3 months time horizon. Increasing Heidelberg Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Heidelberg stock is determined by what a typical buyer is willing to pay for full or partial control of Heidelberg Pharma AG. Since Heidelberg Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Heidelberg Stock. However, Heidelberg Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.56 | Real 2.11 | Hype 2.56 | Naive 2.31 |
The intrinsic value of Heidelberg Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Heidelberg Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Heidelberg Pharma AG helps investors to forecast how Heidelberg stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heidelberg Pharma more accurately as focusing exclusively on Heidelberg Pharma's fundamentals will not take into account other important factors: Heidelberg Pharma Total Value Analysis
Heidelberg Pharma AG is currently expected to have takeover price of 194.72 M with market capitalization of 173.26 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Heidelberg Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
194.72 M | 173.26 M |
Heidelberg Pharma Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Heidelberg suggests not a very effective usage of assets in March.Heidelberg Pharma Profitability Analysis
The company reported the revenue of 1.75 M. Net Loss for the year was (26.14 M) with profit before overhead, payroll, taxes, and interest of 0.About Heidelberg Pharma Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Heidelberg Pharma AG. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Heidelberg Pharma based exclusively on its fundamental and basic technical indicators. By analyzing Heidelberg Pharma's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Heidelberg Pharma's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Heidelberg Pharma. We calculate exposure to Heidelberg Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Heidelberg Pharma's related companies.8 Steps to conduct Heidelberg Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Heidelberg Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Heidelberg Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Heidelberg Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Heidelberg Pharma's revenue streams: Identify Heidelberg Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Heidelberg Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Heidelberg Pharma's growth potential: Evaluate Heidelberg Pharma's management, business model, and growth potential.
- Determine Heidelberg Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Heidelberg Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Heidelberg Stock
Heidelberg Pharma financial ratios help investors to determine whether Heidelberg Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Heidelberg with respect to the benefits of owning Heidelberg Pharma security.